In breast cancer and oral squamous cell carcinoma, changes in Bmi-1 expression did not affect p16Ink4a expression, suggesting that the oncogenic activity of Bmi-1 functions through a p16Ink4a-independent signaling pathway (71, 72). The gene discussed is CDKN2A; the disease is breast cancer.